BeOne Medicines Beats Earnings Estimates and Raises Annual Guidance
ONC BeOne Medicines Ltd ADR
$417.33 +2.55%
View chart & analysis → - 1BeOne Medicines reported adjusted EPS of $3.64, exceeding the consensus of $2.34.
- 2BeOne Medicines achieved a year-over-year earnings growth rate of 233.9%.
- 3BeOne Medicines recorded revenue of $1.89 billion.
So what's the key point?
BeOne Medicines reported higher earnings than experts expected. The company grew 233.9% compared to last year and recorded $1.89 billion in revenue.
Source Earnings Whispers · View original ↗
Today's 5 AI picks, all freeNothing hidden: past picks and how they did against the S&P 500.